Login
$FGC
$6.00 +$0.16 (2.74%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Cash and cash equivalents
Accounts receivable (net of credit allowances of $82 and $74)
Inventories, net
ETH digital assets
Equity securities, at fair value (cost basis of $0 and $8,679)
Other investments
Investments
Equity method investment
Other equity securities and other holdings
Digital intangible assets, at cost less impairment
Equity holdings
Property, plant and equipment, net
Operating lease right-of-use assets
Finance lease right-of-use assets
Deferred policy acquisition costs
Reinsurance balances receivable (net of current expected losses allowance of $96 and $0, respectively)
Funds deposited with reinsured companies
Goodwill
Assets of discontinued operations
Assets held for sale
Receivable from sale of ETH digital assets
Other assets
Total assets
LIABILITIES
Accounts payable and accrued expenses
Deferred revenue and customer deposits
Loss and loss adjustment expense reserves
Unearned premium reserves
Accounts payable
Operating lease liabilities
Finance lease liabilities
Short-term debt, net of issuance costs
Long-term debt, net of debt issuance costs
Deferred income taxes, net
Liabilities of discontinued operations
Other liabilities
Total liabilities
STOCKHOLDERS’ EQUITY
Series A Preferred Shares, $25.00 par and liquidation value, 10,000,000,000 shares authorized, 620,818 shares issued and outstanding as of June 30, 2026 and 888,884 shares issued and outstanding as of December 31, 2025
Common stock, $0.001 par value; 180,000,000,000 shares authorized, 8,720,631 issued and 5,609,758 outstanding as of June 30, 2026 and 8,698,994 issued and 7,080,747 outstanding as of December 31, 2025
Treasury stock (3,110,873 and 1,618,248 shares at cost as of June 30, 2026 and December 31, 2025, respectively)
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Equity attributable to non-controlling interest
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support